
Epic Sciences: A medical diagnostics firm specializing in circulating tumor cell analysis.
Epic Sciences, founded to advance medical diagnostics, specializes in characterizing circulating tumor cells (CTCs). The company's core mission is to provide comprehensive cancer profiling through innovative technologies. Their flagship service involves a multi-technology approach using a single blood draw to analyze CTCs, circulating tumor DNA (ctDNA), and immune cells. This service offers critical insights for clinicians and drug developers, particularly in the fields of prostate and breast cancer.
Notable figures affiliated with Epic Sciences include its founders and key investors from the biotech and medical sectors. The company has achieved significant milestones, including the development of proprietary CTC capabilities and successful partnerships with leading biopharma companies. Epic Sciences' impact is evident in its contributions to precision medicine, offering enhanced diagnostic clarity and aiding in the development of targeted cancer therapies.

Epi One
epi-one.com

Epinoma
epinoma.com
OnCirc Diagnostics

Exact Sciences
exactsciences.com

Circulogene Theranostics
circulogene.com

Castle Biosciences

Amplified Sciences

Biocept

Capio Biosciences

BioFluidica
biofluidica.com

Freenome
freenome.com

Guardant Health
guardanthealth.com

BloodQ
bloodq.com

Precipio
precipiodx.com

AxonDx
axondx.com
Companies similar to Epic Sciences include Epi One, Epinoma, OnCirc Diagnostics and Exact Sciences.
Epic Sciences was founded in 2008.
Epic Sciences' headquarters is located in San Diego, CA, US.
Epic Sciences' most recent funding round was for $24M (USD) in April 2023.
As of Apr 14, 2023, Epic Sciences has raised a total of $219.5M (USD).
Epic Sciences has 114 employees as of Feb 4, 2024.